Market Research Reports

Cardiovascular Devices Market (Monitoring & Diagnostic) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2011 - 2016

108pages
Published Date: 2011-11-15
 

Description




OBJECTIVES OF THE RESEARCH

  • Defining and measuring Global Cardiovascular Monitoring and Diagnostic devices market  with respect to products, services and technologies
  • To analyze the market structure by figuring out diverse sub-segments of the Global Cardiovascular devices market
  • Forecast revenues of the Global Cardiovascular Monitoring and Diagnostic Devices industry and its diverse submarkets with respect to twelve main geographies of the U.S., Canada,  the U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil
  • Recognizing the major market tendency and features driving or hindering growth of the  global Cardiovascular Monitoring and Diagnostic devices market and its diverse  submarkets
  • Strategically analyze each submarket with respect to individual growth trends and contribution to the overall Cardiovascular Monitoring and Diagnostic devices market
  • Analyze opportunities in the market for stakeholders by identifying high-growth segments of the global Cardiovascular Monitoring and Diagnostic devices industry
  • Follow and evaluate competitive growth like alliances, joint ventures, mergers and acquisitions in the global Cardiovascular Monitoring and Diagnostic devices industry.

REPORT DESCRIPTION

Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. It also includes the devices such as interventional cardiology, cardiac rhythm management, cardiac assist devices, peripheral vascular devices, cardiac surgery, devices used to monitor cardiac events and cardiac prosthetic devices to record the electrophysiological impulses of the heart and to analyze and diagnose any abnormality related to the cardiac function. 

Cardiovascular Monitoring and Diagnostic devices are used to detect and provide feedback of abnormal episodes of electrical functioning of the heart. The Cardiovascular  Monitoring & Diagnostic devices include Holter and event recorders, ECG recorders and  ECG stress testing.

This report analyses the Cardiovascular Monitoring and Diagnostic devices into four sub- categories, which includes:

  • ECG monitoring equipment is used to record the Electrocardiogram, ECG which are the intrinsic electrical signals generated in the heart.
  • ECG stress test or Tread Mill Test (TMT) is a diagnostic device used to record the ECG by subjecting the heart to excessive workload. These systems measure the performance of the heart at various stress levels and help physicians in disease diagnosis and deciding treatment protocol.
  • Event monitors or recorders are devices used to record only the abnormal events of the ECG over an extended period of time.
  • Holter monitors are devices used to record the ECG for a 24-hour period and to identify abnormal episodes of the ECG.

The report forecasts all the sub-categories by regional markets. It also identifies and analyzes the market trends, drivers, inhibitors and opportunities present in each. The key players and their growth strategies have also been analyzed and explained in the  report.

SCOPE OF THE REPORT

The report categorizes the global Cardiovascular Monitoring and Diagnostic devices industry into four main subcategories: ECG Monitoring Devices, Holter Monitoring Devices, ECG Stress Testing Devices, and Event Monitoring Devices. In addition to market sizes and forecasts, the report identifies and analyzes trends and opportunities for each of the twelve submarkets; providing 48 market tables for submarkets in the U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil.

Table of Contents




CHAPTER 1 INTRODUCTION

1.1 OBJECTIVES OF THE RESEARCH
1.2 REPORT HIGHLIGHTS
1.3 SCOPE OF THE REPORT
1.4 RESEARCH METHODOLOGY

CHAPTER 2 CARDIOVASCULAR DEVICE MARKET

2.1 INTRODUCTION
      2.1.1 CARDIOVASCULAR DISEASE & DEVICES – DEFINITION
      2.1.2 HISTORY OF CARDIOVASCULAR DEVICES
2.2 CARDIOVASCULAR DEVICE & DIAGNOSIS MARKET
2.3 CARDIOVASCULAR DISEASE
      2.3.1 CARDIOVASCULAR OPERATIONS & PROCEDURES

CHAPTER 3 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES

3.1 BACKGROUND
3.2 NEED FOR CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES
   3.2.1 IMPROVING STANDARDS OF CARE IN HIGH RISK SURGERY
   3.2.2 REDUCING ADVERSE EVENTS
   3.2.3 REDUCING COSTS
3.3 CURRENT TECHNOLOGIES & MARKET TRENDS
3.4 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES, MARKET SEGMENTATION
      3.4.1 ECG MONITORING EQUIPMENT
      3.4.2 HOLTER MONITOR
      3.4.3 STRESS TESTING
      3.4.4 CARDIAC MONITOR
              3.4.4.1 Preparation
              3.4.4.2 Aftercare
              3.4.4.3 Normal results
 

CHAPTER 4 GLOBAL CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET

4.1 INTRODUCTION
4.2 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET IN THE UNITED STATES
      4.2.1 HEALTHCARE OVERVIEW
      4.2.2 THE U.S. CARDIOVASCULAR DISEASE PREVALENCE & MORTALITY RATES
4.3 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN THE U.K. 
4.4 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN GERMANY
4.5 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES IN FRANCE
4.6 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN ITALY
4.7 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN SPAIN
4.8 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN JAPAN
4.9 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN CHINA
4.10 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN INDIA
4.11 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN AUSTRALIA
4.12 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN BRAZIL
4.13 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN CANADA

CHAPTER 5 GROWTH DRIVERS & MARKET TRENDS

5.1 GROWTH DRIVERS
   5.1.1 AGEING POPULATION
   5.1.2 RISING CASES OF CARDIOVASCULAR DISEASES & GROWING AWARENESS
   5.1.3 FAVORABLE REIMBURSEMENT APPROVALS
   5.1.4 GROWTH IN INNOVATIVE TECHNOLOGY PRODUCTS. 
5.2 MARKET TRENDS
   5.2.1 NEW PRODUCT INNOVATION PIONEERED BY ADVANCED TECHNOLOGY
   5.2.2 CRM MARKET POISED TO GROWTH
   5.2.3 INDUSTRY CONSOLIDATION THROUGH INCREASING NUMBER OF MERGERS & ACQUISITIONS
   5.2.4 GROWTH OF WIRELESS REMOTE FOLLOW-UP CAPABILITIES

CHAPTER 6 PRODUCT PIPELINE ANALYSIS

6.1 CARDIO3KG
6.2 CARDIOBIP
6.3 SIGNALIFE FIDELITY 200/FIDELITY 350/FIDELITY 400
6.4 FLOWWAVE 1000
6.5 ESO HEART MONITORING DEVICE
6.6 HEART VITAL SIGNS (HVS) 
6.7 HF PRESSURE MEASUREMENT SYSTEM
6.8 SCHILLER AG’S NEW PRODUCT LINE (BASED ON HYPERQTM TECHNOLOGY) 
6.9 REMONTM IMPRESSURE
6.10 GUARDIAN CARDIAC MONITOR AND ALERT SYSTEM DEVICE
6.11 VENTRIPOINT'S VMS(TM) DIAGNOSTIC TOOL

CHAPTER 7 MERGERS & ACQUISTIONS IN THE CARDIOVASCULAR MONITORING SPACE

7.1 FEB 2007 - CARDIONET ANNOUNCED ACQUISITION OF PDS HEART
7.2 NOV 2010 – CARDIONET ACQUIRED BIOTEL
7.3 OCT 2010 - OPTO CIRCUITS TO ACQUIRE CARDIAC SCIENCE
7.4 JUNE 2009 - SONOSITE ANNOUNCED PLANS TO ACQUIRE CARDIODYNAMICS
7.5 NOV 2010 - ST. JUDE MEDICAL INVESTED $60M IN CARDIOMEMS

CHAPTER 8 KEY COMPETITORS PROFILES

8.1 GE HEALTHCARE
   8.1.1 BUSINESS OVERVIEW
   8.1.2 SEGMENTS
   8.1.3 KEY PRODUCTS
   8.1.4 KEY DEVELOPMENTS
8.2 PHILIPS HEALTHCARE
   8.2.1 BUSINESS OVERVIEW
   8.2.2 SEGMENTS
   8.2.3 KEY PRODUCTS
8.3 NIHON KOHDEN
   8.3.1 BUSINESS OVERVIEW
   8.3.2 SEGMENTS
   8.3.3 KEY PRODUCTS
   8.3.4 KEY DEVELOPMENTS
8.4 SCHILLER AG
   8.4.1 BUSINESS OVERVIEW
   8.4.2 SEGMENTS
   8.4.3 KEY PRODUCTS
8.5 OPTO CIRCUITS (INDIA) LIMITED
   8.5.1 BUSINESS OVERVIEW
   8.5.2 SEGMENTS
   8.5.3 KEY PRODUCTS
   8.5.4 KEY DEVELOPMENTS
8.6 WELCH ALLYN
   8.6.1 BUSINESS OVERVIEW
   8.6.2 KEY PRODUCTS & DEVELOPMENTS
8.7 OSI SYSTEMS
   8.7.1 BUSINESS OVERVIEW
   8.7.2 SEGMENTS AND KEY PRODUCTS
   8.7.3 KEY DEVELOPMENTS
8.8 FUKUDA DENSHI CO LTD. 
   8.8.1 BUSINESS OVERVIEW
   8.8.2 SEGMENTS
   8.8.3 KEY PRODUCTS
   8.8.4 KEY DEVELOPMENTS
8.9 LIDCO GROUP PLC
   8.9.1 BUSINESS OVERVIEW
   8.9.2 SEGMENTS
   8.9.3 KEY PRODUCTS
   8.9.4 KEY DEVELOPMENTS
8.10 ST. JUDE MEDICAL INC
    8.10.1 BUSINESS OVERVIEW
    8.10.2 SEGMENTS
    8.10.3 KEY PRODUCTS
    8.10.4 KEY DEVELOPMENTS
8.11 JOHNSON & JOHNSON
    8.11.1 BUSINESS OVERVIEW
    8.11.2 SEGMENTS
    8.11.3 KEY PRODUCTS
8.12 BIOTRONIK INC
    8.12.1 BUSINESS OVERVIEW
    8.12.2 SEGMENTS
    8.12.3 KEY PRODUCTS
    8.12.4 KEY DEVELOPMENTS
8.13 DRAGER MEDICAL GMBH
    8.13.1 BUSINESS OVERVIEW
    8.13.2 SEGMENTS
    8.13.3 KEY PRODUCTS
    8.13.4 KEY DEVELOPMENTS
8.14 EDWARDS LIFESCIENCES CORPORATION
    8.14.1 BUSINESS OVERVIEW
    8.14.2 SEGMENTS
    8.14.3 KEY PRODUCTS
    8.14.4 KEY DEVELOPMENTS
8.15 MEDTRONIC INC
    8.15.1 BUSINESS OVERVIEW
    8.15.2 SEGMENTS
    8.15.3 KEY PRODUCTS
    8.15.4 KEY DEVELOPMENTS
8.16 OMRON HEALTHCARE
    8.16.1 BUSINESS OVERVIEW
    8.16.2 SEGMENTS
    8.16.3 KEY PRODUCTS
8.17 BMEYE B.V. 
    8.17.1 BUSINESS OVERVIEW
    8.17.2 SEGMENTS
    8.17.3 KEY PRODUCTS
    8.17.4 KEY DEVELOPMENTS

FIG. 1 GLOBAL BREAKUP OF CAUSE OF MORTALITY (2008) 
FIG. 2 BREAKDOWN OF DEATHS FROM CVDS (U.S. 2006) 
FIG. 3 NUMBER OF CARDIAC OPERATIONS IN THE UNITED STATES
FIG. 4 MARKET SEGMENTATION
FIG. 5 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, SEGMENTATION (2010) 
FIG. 6 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE BY SEGMENT, 2004 – 2010 (USD MILLION) 
FIG. 7 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME BY SEGMENT, 2004 – 2010 (UNITS) 
FIG. 8 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE BY SEGMENT (USD MILLION): FORECAST (2010 – 2016) 
FIG. 9 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME BY SEGMENT (UNITS): FORECAST (2010 – 2016) 
FIG. 10 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, MARKET SHARE (2010) 
FIG. 11 GLOBAL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, MARKET SHARE (2010) 
FIG. 12 PREVALENCE OF CARDIO DISEASES IN ADULTS
FIG. 13 THE U.S. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE BY SEGMENT ($ M) - HISTORIC TREND
FIG. 14 THE U.S. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - HISTORIC TREND
FIG. 15 THE U.S. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 16 THE U.S. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 17 THE U.K. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 18 THE U.K. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 19 THE U.K. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 20 THE U.K. CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 21 GERMANY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 22 GERMANY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 23 GERMANY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 24 GERMANY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 25 FRANCE CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 26 FRANCE CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 27 FRANCE CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 28 FRANCE CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 29 ITALY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 30 ITALY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 31 ITALY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 32 ITALY CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 33 SPAIN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 34 SPAIN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 35 SPAIN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 36 SPAIN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 37 JAPAN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 38 JAPAN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 39 JAPAN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 40 JAPAN CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 41 CHINA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 42 CHINA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 43 CHINA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 44 CHINA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 45 INDIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 46 INDIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 47 INDIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 48 INDIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 49 AUSTRALIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 50 AUSTRALIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 51 AUSTRALIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 52 AUSTRALIA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 53 BRAZIL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 54 BRAZIL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 55 BRAZIL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 56 BRAZIL CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 57 CANADA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) – HISTORIC TREND
FIG. 58 CANADA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) – HISTORIC TREND
FIG. 59 CANADA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, REVENUE (USD MILLION) - FORECAST
FIG. 60 CANADA CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES, VOLUME (UNITS) - FORECAST
FIG. 61 WORLDWIDE AGING POPULATION TREND 

Cardiovascular Devices Market And Cardiovascular Market

NA

Enquiry Before Buying




Free Market Analysis




Market Snapshot


Every year, millions of people die of cardiovascular diseases that are caused due to improper functioning of the heart and blood vessels. It results in complications such as Cardiac Arrhythmias, Sudden Cardiac Arrest (SCA), Congestive Heart Failure (CHF), Acute Myocardial Infarction (AMI), and Atherosclerosis. The key factors driving the growth of Cardiovascular monitoring devices are growing health awareness, the ageing population, increasing patient base undergoing cardiac procedures and life saving benefits of cardiovascular devices. With the progression in modern technologies, companies are bringing up next generation devices that involve minimal invasive methods. The considerable practice of biocompatible and bio absorbable materials will always be the driving force behind the modernization in the market of cardiovascular monitoring and diagnostic devices.

Cardiovascular devices, in medical equipment industry represents one of the most important markets that consists of Interventional Cardiology (IC) devices, Cardiac Rhythm Management (CRM) devices, Cardiovascular Monitoring and Diagnostics Devices, Cardiovascular Prosthetic, and Cardiovascular Surgery devices.

Cardiovascular Disease (CVD) is still the top most cause for human death globally accounting to a whopping 17 million per annum. Around 30 million people are severely affected by cardiovascular diseases every year. A considerable market growth is provided in the stress testing systems and diagnostics all over the world by the emerging markets.

There are two sub-segments accounting for the high demand—cardiac rhythm management and cardiovascular monitoring and diagnostic devices. Of the many factors leading to the soaring demand for cardiovascular devices, an aging population, changing lifestyle and technological advances are the main ones. The economic downturn has affected the cardiovascular firms resulting in increased outsourcing. M&A has also become one of the strategies of the companies to grow and cope up with the situation.

The World Health Organization (WHO) estimates that cardiovascular diseases are the largest cause of deaths globally, around 17.3 million people died from cardiovascular diseases in 2008. This amounts to 30% of all deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease and 6.2 million were due to stroke. Low- and middle-income countries are the largest affected with CVDs. An estimated 80% of CVD deaths take place in low- and middle-income countries.

The World Health Organization (WHO) estimates that cardiovascular diseases are the largest cause of deaths globally, around 17.3 million people died from cardiovascular diseases in 2008. This amounts to 30% of all deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease and 6.2 million were due to stroke. Low- and middle-income countries are the largest affected with CVDs. An estimated 80% of CVD deaths take place in low- and middle-income countries. By 2030, almost 23.6 million people will die from CVDs, mainly from heart disease and stroke and are projected to be the single leading causes of death.

The global CMD devices market has experienced a high growth in terms of the units sold. ECG monitoring equipment topped all the four segments. Growth in the number of units is driven by the large amount of production; marketing tactics used by large Med-Tech companies and increased usage by medical facilities.

cardiovascular-monitoring-and-diagnostics-devices
An estimated 81,100,000 American adults (more than one in three) have one or more types of Cardiovascular Diseases (CVD). Of these, 38,100,000 are estimated to be in the age group 60 years or older. Total CVD includes diseases in the bullet points below except for congenital CVD. Due to overlap, it is not possible to add these conditions to arrive at a fixed total. High blood pressure (HBP)—74,500,000 (defined as systolic pressure 140 mm Hg or greater and/or diastolic pressure 90 m Hg or greater, taking antihypertensive medication or being told at least twice by a physician or other health professional that you have HBP)

The U.K. CMD devices market has grown at a high rate of 12.1% since 2004. The biggest growth driver in the U.K. market has been the increasing population suffering from several heart problems. The growth is predominantly import-led as many domestic manufacturers are not able to rapidly adjust to the changing trends seen in demand.

The Chinese CMD devices market has experienced a moderate growth in the past years. Major drivers such as advancement in digital and biomedical technologies, increase in the ageing population and rise in the affluent population have led to a rise in the demand for medical devices in China.

The increased requirement for cardiovascular devices can be accounted to the growth in the ageing population in the emerging and developed nations. The focus of the European and Asian countries are to deliver efficient health services in the future. A platform for mutual alliance between the patients and healthcare providers has been planned in Europe that would allow the sharing and suggesting information by the member states about the regulatory policies. Additionally, the platform would enhance the alertness and usage of cardiovascular devices.

worldwide-aging-population-trend
With the advancement in technology better therapies and solutions have been introduced into the healthcare market. Further, due to the intense competition in the market, competitors are driven to introduce new cardiovascular monitoring devices. Also, manufacturers are emphasizing on next generation cardiovascular devices with improved design, deliverability, and conformability. 

The new products launched by various healthcare equipment manufacturers can be good examples of this. The new ECG monitors, CardioBip and Cardio3KG, of NewCardio, Inc. are capable of generating quick results which are being clinically tried. Also, companies producing new devices with wireless techniques, e.g. Heart Vital Signs, a remote cardiac monitoring device by Medical Care Technologies, Inc., are in the process of their clinical trials.
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research